Protein kinase C activation reduces microglial cyclic AMP response to prostaglandin E2 by interfering with EP2 receptors

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 400-405

  Patrizio, Mario ^a   Colucci, Mariantonella ^a   Levi, Giulio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Brain macrophages; Butaprost; Microglial cultures; Prostaglandin receptors

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2 METHYL ESTER; ADENYLATE CYCLASE; BUTAPROST; CYCLIC AMP; DIACYLGLYCEROL; PHORBOL 12 ACETATE 13 MYRISTATE; PHORBOL DIDECANOATE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE C; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; ENZYME ACTIVATION; INFLAMMATION; MACROPHAGE; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALS; CELLS, CULTURED; CYCLIC AMP; DINOPROSTONE; ENZYME ACTIVATION; MICROGLIA; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA;

EID: 0033985188     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740400.x     Document Type: Article

References (51)

1. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663, 237-243.
2. Aloisi F., Penna G., Cerase J., Menèndez-Iglesias B., and Adorini L. (1997) IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159, 1604-1612.
3. 2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro-and anti-inflammatory activities. J. Neurosci. Res. 56, 571-580.
4. 2. Biochem. Biophys. Res. Commun. 197, 263-270.
5. Ballestas M. E. and Benveniste E. N. (1995) Interleukin 1-β-and tumor necrosis factor-α-mediated regulation of ICAM-1 gene expression in astrocytes requires protein kinase C activity. Glia 14, 267-278.
6. Bouvier M. (1992) Cross-talk between second messengers. Ann. NY Acad. Sci. 39, 120-129.
7. Caggiano A. O. and Kraig R. P. (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1βproduction. J. Neurochem. 72, 565-575.
8. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., and Nishizuka Y. (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol Chem. 257, 7847-7851.
9. 2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury. Neurosci. Lett. 160, 106-108.
10. Cazevieille C., Muller A., Meynier F., Dutrait N., and Bonne C. (1994) Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24, 395-398.
11. Chen J., Marsh T., Zhang J. S., and Graham S. H. (1995) Expression of cyclo-oxygenase 2 in rat brain following kainate treatment. Neuroreport 6, 245-248.
12. Coleman R. A., Smith W. L., and Narumiya S. (1994) Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205-229.
13. Farooqui A. A. and Horrocks L. A. (1991) Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 16, 171-191.
14. Fretland D. J. (1992) Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis. Prostaglandins Leukotrienes Ess. Fatty Acids 45, 249-257.
15. Fujihara M., Connolly N., Ito N., and Suzuki T. (1994) Properties of protein kinase C isoforms (βII, ε, and zeta) in a macrophage cell line (J774) and their roles in LPS-induced nitric oxide production. J. Immunol. 152, 1898-1906.
16. Gardiner P. J. (1986) Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979. Br. J. Pharmacol 87, 45-56.
17. Giulian D. (1987) Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18, 155-171.
18. Griffin D. E., Wesselingh S. L., and McArthur J. C. (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35, 592-597.
19. 2 subtype. J. Biol. Chem. 268, 7759-7762.
20. Jun C.-D., Choi B.-M., Hoon-Ryu Um J.-Y., Kwak H.-J., Lee B.-S., Paik S.-G., Kim H.-M., and Chung H.-T. (1994) Synergistic cooperation between phorbol ester and IFN-gamma for induction of nitric oxide synthesis in murine peritoneal macrophages. J. Immunol. 153, 3684-3690.
21. Kanai N., Lu R., Satriano J. A., Bao Y., Wolkoff A. W., and Schuster V. L. (1995) Identification and characterization of a prostaglandin transporter. Science 268, 866-869.
22. Kikkawa U., Takai Y., Tanaka Y., Miyake R., and Nishizuka Y. (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 258, 11442-11445.
23. Kitanaka J., Hashimoto H., Gotoh M., Kondo K., Sakata K., Hirasawa Y., Sawada M., Suzuruma A., Marunouchi T., Matsuda T., and Baba A. (1996) Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures. Brain Res. 707, 282-287.
24. Kobayashi E., Nakano H., Morimoto M., and Tamaoki T. (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159, 548-553.
25. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
26. Levi G., Patrizio M., Bernardo A., Petrucci T. C., and Agresti C. (1993) Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. USA 90, 1541-1545.
27. 2 on microglial functions. Biochimie 80, 899-904.
28. McMillian M. K., Vainio P. J., and Tuominen R. K. (1997) Role of protein kinase C in microglia-induced neurotoxicity in mesencephalic cultures. J. Neuropathol. Exp. Neurol 56, 301-307.
29. 2 and cyclic AMP-elevating agents. J. Neuroimmunol. 72, 83-93.
30. Minghetti L. and Levi G. (1995) Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65, 2690-2698.
31. Minghetti L. and Levi G. (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54, 99-125.
32. 2 and by cyclooxygenase inhibitors. Glia 19, 152-160.
33. 2, cyclic AMP and non steroidal anti-inflammatory drugs. Eur. J. Neurosci. 9, 934-940.
34. Narumiya S. (1996) Prostanoid receptors and signal transduction. Prog. Brain Res. 113, 231-241.
35. Negishi M., Sugimoto Y., and Ichikawa A. (1995) Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1259, 109-119.
36. Nishigaki N. M., Negishi M., Honda A., Sugimoto Y., Namba T., Narumiya S., and Ichikawa A. (1995) Identification of prostaglandin E receptor EP2 cloned from mastocytoma cells as EP4 subtype. FEBS Lett. 364, 339-341.
37. 1 induces c-Fos and Myc proteins and protects rat hippocampal cells against hypoxic injury. J. Cereb. Blood Flow Metab. 14, 150-155.
38. Patrizio M., Costa T., and Levi G. (1995) Interferon-γ and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor. Glia 14, 94-100.
39. Patrizio M., Riitano D., Costa T., and Levi G. (1996) Selective enhancement by serum factors of cyclic AMP accumulation in microglia cultures. Neurochem. Int. 29, 89-96.
40. Patrizio M., Slepko N., and Levi G. (1997) Opposite regulation of adenylyl cyclase by protein kinase C in astrocyte and microglia cultures. J. Neurochem. 69, 1267-1277.
41. Reder A. T. and Arnason B. G. W. (1995) Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 45, 1097-1100.
42. Reder A. T., Thapar M., Sapugay A. M., and Jensen M. A. (1994) Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis. J. Neuroimmunol. 54, 117-127.
43. Sands W. A., Bulut V., Severn A., Xu D., and Liew F. Y. (1994) Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. Eur. J. Immunol. 24, 2345-2350.
44. Shapira L., Takashiba S., Champagne C., Amar S., and Van Dyke T. E. (1994) Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-α and IL-1β production by human monocytes. J. Immunol. 153, 1818-1824.
45. Shimizu T. and Wolfe L. S. (1990) Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 1-15.
46. Smith W. L. (1992) Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol. 263, F181-F191.
47. 2 and a β-adrenergic agonist. Glia 11, 383-386.
48. 2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92, 40-45.
49. 65 as an essential thiol. J. Biol. Chem. 270, 1422-1428.
50. + channel profile of microglial cells. J. Neurosci. Res. 47, 233-241.
51. 2 receptors on U937 human monocytic cells. Immunology 86, 620-628.